Skip to content

Observational Study of Ostomy Consumers

Observational Study of Ostomy Consumers

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03715179
Acronym
OSO
Enrollment
5000
Registered
2018-10-23
Start date
2018-10-04
Completion date
2027-02-01
Last updated
2026-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ostomy

Brief summary

The purpose of this longitudinal prospective observational study is to collect electronic Patient Reported Outcome (ePRO) data over a 7-year period directly from people living with an ostomy and their caregivers (participants were re-consented with version 3 of the Protocol in 2020 which indicated a study duration of 5 years, and version 6 of the Protocol in 2025 extending for an additional 2 years). Research participants will be asked to self-report on the ostomy pouching systems they typically use and other various aspects of living with an ostomy and/or caring for an individual living with an ostomy.

Detailed description

This longitudinal prospective observational study is designed as an ePRO registry to collect data from consumers with an ostomy (ileostomy, colostomy, or urostomy) in the United States, Canada, and United Kingdom. An ePRO registry provides a relevant data source founded on the patient's voice. As such, an ePRO registry will be invaluable for prospective observational research aiming to investigate associations of ostomy pouching systems (inclusive of accessories) with peristomal skin health, participant QoL, caregiver burden, product satisfaction, and Healthcare Resource Utilization (HRU). Information from this registry will inform and guide industry healthcare providers and payers in decision-making and subsequent research that factors in the patient and caregiver perspectives. The current study does not test any specific a priori hypotheses.

Interventions

None listed

Sponsors

Hollister Incorporated
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Is at least 18 years of age; any self-reported gender 2. Has a single Ileostomy, Colostomy, or Urostomy 3. Is able to provide an informed consent for study participation with no cognitive impairment that would hinder the ability to provide informed consent or provide self-reported data 4. Is willing and able to complete a once per month online questionnaire about life with an ostomy, or has a proxy who can enter data on their behalf 5. Are able to respond themselves or appoint a caregiver as a proxy to respond to online computer questionnaires in English, French Canadian, or Spanish Caregivers will be entered into this study only if they meet all of the following criteria: 1. Is at least 18 years of age; any self-reported gender 2. Is an informal supporter (such as a relative, friend, or neighbor) of the care recipient 3. Provides support to the care recipient in some capacity (such as ordering supplies or pouch changes) on average at least once per week

Exclusion criteria

1. Has more than one stoma 2. Has a single stoma that has been reversed or closed

Design outcomes

Primary

MeasureTime frameDescription
To create a patient reported outcomes registry of ostomy consumers7 yearsTo collect prospective observational data through a patient reported outcome (PRO) registry that will serve as a platform to conduct multiple analyses.

Secondary

MeasureTime frameDescription
Ostomy specific outcomes7 yearsTo identify and characterize ostomy specific outcomes for the purposes of hypothesis generation.
Product specific outcomes7 yearsTo identify and characterize product specific outcomes related to the ostomy specific outcomes.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORRenee Malandrino, MSN RN CWOCN

Hollister Incorporated

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026